InvestorsHub Logo

freethemice

10/15/12 3:54 PM

#99285 RE: nuke661 #99284

From the Acknowledgments section of the paper

We would like to thank Philip Thorpe and Nicholas van Bruggen
for helpful discussions, Peregrine Pharmaceuticals, Inc. for providing PGN635,

...
It is research, but I am sure Genentech always has their eye on the future uses of any research they do.

exwannabe

10/15/12 4:20 PM

#99291 RE: nuke661 #99284

On Zr-89 vs I-124

Seams like I-124 has been used much more often for practical reasons. The half life is a day longer and the chemistry was simpler. Zr-89 has some benfits wrt the emissions.

Here is a site that has some info :
http://www.cyclotron.nl/diagnostic-radiochemicals-and-radionuclides__2_3

As to DNA working on this, that is very common. PPHM certainly would still have it's rights, but Roach would also be able to patent the combination. They would have to come to terms if this was found to be of sufficient value to carry forward.